A Carlsberg Spinout Is Selling Gene-Editing Outcomes Without the Gene-Editing

The Copenhagen biotech, spun out of Carlsberg's lab, is commercializing a high-throughput screening platform that finds useful genetic variants without genetic engineering.

About Traitomic

Published

The screen presents a grid, a galaxy of tiny green dots, each one a barley seed. An algorithm, trained to ignore the noise of a million base pairs, pinpoints the single genetic variant that makes one dot slightly more resilient, slightly more nutritious. This is the FIND-IT platform at work, a piece of software born in a brewery lab that is now the core product of Traitomic, a Copenhagen biotech selling nature’s own edits back to the industries that feed us.

Traitomic’s bet is not on inventing new biology but on becoming the world’s most systematic cataloger of the biology that already exists. Its FIND-IT technology, originally developed at the Carlsberg Research Laboratory to improve barley for beer, screens massive genetic libraries of plants and microorganisms to identify naturally occurring variants linked to desirable traits [Perplexity Sonar Pro Brief]. The commercial promise is a specific kind of alchemy: delivering the productivity and resilience gains associated with gene editing, but through conventional breeding methods that sidestep the regulatory and consumer acceptance hurdles of genetically modified organisms [AgNavigator, November 2026]. For a seed company wanting drought-tolerant wheat or a food ingredient maker seeking a better enzyme, Traitomic offers a path that is, in their framing, both cutting-edge and curiously old-fashioned.

The library of natural variation

The company’s traction is measured not in revenue disclosed, but in the volume of biological discoveries delivered. Traitomic reports it has delivered 116 distinct traits to 47 customers across 32 different organisms, from staple crops to industrial microbes [Perplexity Sonar Pro Brief]. This library is their first product and their primary moat. Each successful trait identification validates the platform’s screening power and adds to a proprietary dataset of genotype-to-phenotype relationships that becomes more valuable with scale.

The workflow is a service. A customer presents a problem, like quinoa seeds that contain bitter, soapy saponins requiring extensive washing. Traitomic uses FIND-IT to screen quinoa populations for natural mutants lacking the saponin-producing genes, a technique it showcased in a published collaboration [TraitSource, Saponin-Free Quinoa]. They then deliver the identified genetic lines back to the customer for conventional cross-breeding. The company’s stated customer segments are broad, spanning plant breeding, food and precision nutrition, and industrial biotechnology [Perplexity Sonar Pro Brief]. This cross-organism approach is strategic, allowing the company to diversify beyond any single agricultural commodity cycle.

A spinout with industrial pedigree

The team carries the deep, practical imprint of its Carlsberg origins. CEO Gustav Hambraeus spent over two decades as a researcher at the brewery, giving him an operator’s view of scaling biological processes [Seed World, December 2023]. Co-founder and COO Toni Wendt was a co-inventor of the FIND-IT technology during her time on the same Carlsberg team [Perplexity Sonar Pro Brief]. This is not a story of academics chasing a paper, but of industrial researchers who spent years solving a real problem for a single, demanding customer before productizing the solution for a global market. The commercial lead, co-founder Jan Gottlieb, rounds out a founding trio built for the long commercial haul from lab to field [Jan Gottlieb on LinkedIn].

Their November 2026 Series A round, a €20 million (approximately $22 million) raise led by Sofinnova Partners, signals investor belief in that commercialization path [AgFunderNews, November 2026]. The syndicate includes EIFO, The Footprint Firm, and Nordic Foodtech VC, blending life science, climate, and foodtech capital. The proceeds are earmarked for international expansion, further platform development, and scaling customer collaborations [Øresund Startups, November 2026].

Technical architecture and scaling risks

To manage the computational weight of genomic screening, Traitomic runs on AWS HealthOmics, a cloud service tailored for bioinformatics workflows [AWS, April 2026]. This partnership outscores the infrastructure challenge but also anchors their cost structure to cloud compute. The company’s primary competitive insulation is the head start granted by its Carlsberg-developed platform and the growing dataset of validated traits. However, the model faces several natural pressures.

  • The service bottleneck. As a service business, scaling requires linearly adding scientific labor and compute cycles for each new customer project. The path to high-margin, scalable software is less clear.
  • Regulatory arbitrage. Their value proposition hinges partly on the regulatory complexity of GMOs. If global regulations around certain gene-editing techniques (like CRISPR) soften, a key differentiator could erode.
  • The data moat. While their dataset is an asset, the fundamental methodology of screening natural variation is not itself patent-proof. Well-funded agribusiness giants or academic consortia could attempt to build similar capacity in-house.

The company’s most plausible answer is to deepen the moat by moving further up the value chain. This could mean developing and licensing its own proprietary seed varieties based on its discoveries, or building software tools that allow customers to self-serve parts of the discovery process, transitioning from a pure service to a hybrid product model.

What the next crop looks like

With a team of approximately 30 people and fresh capital, Traitomic’s next twelve months will be defined by commercial execution beyond its Nordic base [Øresund Startups, November 2026]. The key milestone to watch is the naming of flagship customers in major agricultural or food ingredient markets, providing external validation of its traction claims. Another signal will be the expansion of its trait library into new, high-value organism categories, demonstrating the platform’s continued versatility.

The cultural question Traitomic is implicitly answering is one of technological humility. In an era obsessed with engineering and editing life from scratch, it proposes a different kind of innovation: what if the better, faster, more acceptable tool is not a new pair of genetic scissors, but a vastly better search engine for the genetic library we already have? Its success would suggest that for many of our pressing problems in food and climate, the code we need is already written in nature. The real breakthrough is learning how to read it.

Sources

  1. [Perplexity Sonar Pro Brief] Traitomic company and product overview
  2. [AgNavigator, November 2026] Traitomic bets on ‘gene-editing outcomes without gene-editing’ after €20m Series A | https://www.agnavigator.com/Article/2026/11/17/traitomic-bets-on-gene-editing-outcomes-without-gene-editing-after-20m-series-a/
  3. [TraitSource, Saponin-Free Quinoa] Saponin-Free Quinoa developed using FIND-IT technology
  4. [Seed World, December 2023] Gustav Hambraeus career background | https://seedworld.com/traitomic-appoints-new-ceo/
  5. [Jan Gottlieb on LinkedIn] Jan Gottlieb role at Traitomic
  6. [AgFunderNews, November 2026] Carlsberg spinout Traitomic lands $22m to speed up trait discovery and development | https://agfundernews.com/carlsberg-spinout-traitomic-lands-22m-to-speed-up-trait-discovery-and-development
  7. [Øresund Startups, November 2026] From Carlsberg's Lab to Its Own Wings: Traitomic Raises €20 Million Series A | https://oresundstartups.com/from-carlsbergs-lab-to-its-own-wings-traitomic-raises-e20-million-series-a-to-take-non-ge-trait-development-worldwide/
  8. [AWS, April 2026] How Carlsberg’s Traitomic business leveraged AWS HealthOmics to power genetic trait development | https://aws.amazon.com/blogs/industries/how-carlsbergs-traitomic-business-leveraged-aws-healthomics-to-power-genetic-trait-development/

Read on Startuply.vc